Study of 4-Demethyl-4-cholesteryloxycarbonylpenclome in Patients With Brain Tumors (DM-CHOC-PEN)

This study is currently recruiting participants. (see Contacts and Locations)
Verified May 2015 by DEKK-TEC, Inc.
Sponsor:
Collaborators:
Tulane University Medical Center, New Orleans, LA
Icahn School of Medicine at Mount Sinai
Detroit Clinical Research Center, Farmington Hills, Lansing and Owasso, MI
Billings Clinic, Billings, MT
Ochsner Medical Center, New Orleans, LA
University of Texas Health Sciences Center and Memorial Hermann Hospital - Texas Med Cntr
Crescent City Research Consortium, New Orleans, LA
Information provided by (Responsible Party):
DEKK-TEC, Inc.
ClinicalTrials.gov Identifier:
NCT02038218
First received: January 15, 2014
Last updated: May 13, 2015
Last verified: May 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: August 2016
  Estimated Primary Completion Date: June 2016 (Final data collection date for primary outcome measure)